Publications

Recent Publications (limited out of 140 total)

Wilkes MC, Siva K, Varetti G, Mercado J, Wentworth EP, Perez C, Saxena M, Km S, Kapur S, Chen J, Narla A, Glader B, Lin S, Serrano M, Flygare J and KM Sakamoto. Metformin-induced Suppression of NLK improves Erythropoiesis in Diamond Blackfan Anemia through Induction of miR26a, Exp Hematol, in press.

Wojcicki AV, Kadapakkam M, Frymoyer A, Lacayo N, Chae HD, Sakamoto KM. Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit? Cancers (Basel). 2020;12(2):441. Published 2020 Feb 13. doi:10.3390/cancers12020441

Ding YY, Ramakrishna S, Long AH, et al. Delayed cancer diagnoses and high mortality in children during the COVID-19 pandemic [published online ahead of print, 2020 Jun 26]. Pediatr Blood Cancer. 2020;e28427. doi:10.1002/pbc.28427

Chae HD, Dutta R, Tiu B, et al. RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit. Oncotarget. 2020;11(25):2387-2403. Published 2020 Jun 23. doi:10.18632/oncotarget.27630

Wojcicki AV, Kasowski MM, Sakamoto KM, Lacayo N. Metabolomics in acute myeloid leukemia. Mol Genet Metab. 2020;130(4):230-238. doi:10.1016/j.ymgme.2020.05.005

Abecasis M, Cross NCP, Brito M, et al. Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia [published online ahead of print, 2020 Jul 6]. Leukemia. 2020;10.1038/s41375-020-0957-z. doi:10.1038/s41375-020-0957-z

Wilkes MC, Siva K, Chen J, Varetti G, Dever DP, Nishimura T, Chae H, Youn MY, Narla A, Glader B, Nakauchi H, Porteus MH, Repellin CE, Gazda TH, Lin S, Serrano M, Flygare J and KM Sakamoto. Diamond Blackfan Anemia is Mediated by Hyperactive Nemo-Like Kinase. Nat Commun, in press.

Huang M, Zeki J, Sumarsono N, Coles GL, Taylor JS, Danzer E, Bruzoni M, Hazard FK, Lacayo NJ, Sakamoto KM , Dunn JCY, Spunt SL and B Chiu. Epigenetic Targeting of Tert-Associated Gene Expression Signatures in Human Neuroblastoma with Tert Overexpression. Canc Res , Jan 3, 2020.

TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors. Bibikova E, Youn MY, Danilova N, Ono-Uruga Y, Konto-Ghiorghi Y, Ochoa R, Narla A, Glader B, Lin S, Sakamoto KM. Blood. 2014 Dec 11;124(25):3791-8. doi: 10.1182/blood-2014-06-584656. Epub 2014 Sep 30. PMID: 25270909 [PubMed – in process]

Letting microRNAs overcome resistance to chemotherapy in acute myeloid leukemia. Sakamoto KM. Leuk Lymphoma. 2014 Jul;55(7):1449-50. doi: 10.3109/10428194.2013.862244. Epub 2014 Jan 28. No abstract available. PMID: 24206095 [PubMed – in process]

Reiss UM, Schwartz J, Sakamoto KM, Puthenveetil G, Ogawa M, Bedrosian, and RE Ware. Efficacy and Safety of Eculizumab in Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria. Pediatr Blood Cancer, April 29, 2014 [Epub ahead of print]

Danilova N, Bibikova E, Covey TM, Nathanson D, Dimitrova E, Lindgren A, Glader B, Radu CG, Sakamoto KM, and S Lin. The Role of DNA damage response in zebrafish and cellular models of Diamond Blackfan Anemia. Disease Models and Mechanisms, 7:895-905, 2014.

MiR-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation. Pigazzi M, Manara E, Bresolin S, Tregnago C, Beghin A, Baron E, Giarin E, Cho EC, Masetti R, Rao DS, Sakamoto KM, Basso G. Haematologica. 2012 Oct 25. [Epub ahead of print] PMID: 23100280 [PubMed – as supplied by publisher] Free Article

Blood. 2012 Jul 5;120(1):155-65. Epub 2012 May 24. Sox4 cooperates with CREB in myeloid transformation. Sandoval S, Kraus C, Cho EC, Cho M, Bies J, Manara E, Accordi B, Landaw EM, Wolff L, Pigazzi M, Sakamoto KM. PMID: 22627767 [PubMed – in process] PMCID: PMC3390953 [Available on 2013/7/5]

Crit Rev Oncog. 2011;16(1-2):37-46. CREB and leukemogenesis. Cho EC, Mitton B, Sakamoto KM. PMID: 22150306 [PubMed – indexed for MEDLINE] PMCID: PMC3243968

Transplantation for congenital bone marrow failure syndromes. Morimoto K, Moore TB, Schiller G, Sakamoto KM. Bone Marrow Res. 2011;2011:849387.

The function of cyclic-adenosine monophosphate responsive element-binding protein in hematologic malignancies. Mitton B, Cho EC, Aldana-Masangkay GI, Sakamoto KM. Leuk Lymphoma. 2011 Nov;52(11):2057-63.

Editorial: granulopoiesis versus monopoiesis: a consequence of transcription factors dancing with the right partners. Sakamoto KM. J Leukoc Biol. 2011 Oct;90(4):637-8.

Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells. Aldana-Masangkay GI, Rodriguez-Gonzalez A, Lin T, Ikeda AK, Hsieh YT, Kim YM, Lomenick B, Okemoto K, Landaw EM, Wang D, Mazitschek R, Bradner JE, Sakamoto KM. Leuk Lymphoma. 2011 Aug;52(8):1544-55.

Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metabolic defects. Danilova N, Sakamoto KM, Lin S. Br J Haematol. 2011 Jan;152(2):217-28.

Increasing diversity in pediatric hematology/oncology. Frugé E, Lakoski JM, Luban N, Lipton JM, Poplack DG, Hagey A, Felgenhauer J, Hilden J, Margolin J, Vaiselbuh SR, Sakamoto KM. Pediatr Blood Cancer. 2011 Jan 31. doi: 10.1002/pbc.22977. [Epub ahead of print] No abstract available. PMID: 21284078 [PubMed – as supplied by publisher] http://www.ncbi.nlm.nih.gov/pubmed/21284078

The multi-targeted receptor tyrosine kinase inhibitor, Linifanib (ABT-869), induces apoptosis through an AKT and Glycogen Synthase Kinase 3{beta}-dependent pathway. Hernandez-Davies JE, Zape JP, Landaw EM, Tan X, Presnell A, Griffith DJ, Heinrich MC, Glaser KB, Sakamoto KM. Mol Cancer Ther. 2011 Apr 6. [Epub ahead of print]

Self-Renewal of Acute Lymphocytic Leukemia Cells Is Limited by the Hedgehog Pathway Inhibitors Cyclopamine and IPI-926.
Lin TL, Wang QH, Brown P, Peacock C, Merchant AA, Brennan S, Jones E, McGovern K, Watkins DN, Sakamoto KM, Matsui W.
PLoS One. 2010 Dec 28;5(12):e15262.

Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metabolic defects.
Danilova N, Sakamoto KM, Lin S.
Br J Haematol. 2011 Jan;152(2):217-28. doi: 10.1111/j.1365-2141.2010.08396.x. Epub 2010 Nov 29.

The role of the transcription factor CREB in immune function.
Wen AY, Sakamoto KM, Miller LS.
J Immunol. 2010 Dec 1;185(11):6413-9. Review.

The role of HDAC6 in cancer.
Aldana-Masangkay GI, Sakamoto KM.
J Biomed Biotechnol. 2011;2011:875824. Epub 2010 Nov 7.

Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia.
Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, Bunda S, Finklestein JZ, Sakamoto KM, Gorr TA, Mehta P, Schmid I, Kropshofer G, Corbacioglu S, Lang PJ, Klein C, Schlegel PG, Heinzmann A, Schneider M, Starý J, van den Heuvel-Eibrink MM, Hasle H, Locatelli F, Sakai D, Archambeault S, Chen L, Russell RC, Sybingco SS, Ohh M, Braun BS, Flotho C, Loh ML.
Nat Genet. 2010 Sep;42(9):794-800. Epub 2010 Aug 8.

Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy.
Wu WK, Sakamoto KM, Milani M, Aldana-Masankgay G, Fan D, Wu K, Lee CW, Cho CH, Yu J, Sung JJ.
Drug Resist Updat. 2010 Jun;13(3):87-92

Targeting CREB for cancer therapy: friend or foe.
Xiao X, Li BX, Mitton B, Ikeda A, Sakamoto KM.
Curr Cancer Drug Targets. 2010 Jun;10(4):384-91.

ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathways.
Ikeda AK, Judelson DR, Federman N, Glaser KB, Landaw EM, Denny CT, Sakamoto KM.
Mol Cancer Ther. 2010 Mar;9(3):653-60. Epub 2010 Mar 2.

Protacs for treatment of cancer.
Sakamoto KM.
Pediatr Res. 2010 May;67(5):505-8.